PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN HSR-803 AND WARFARIN IN HEALTHY SUBJECTS

被引：0
|
作者：
Rufiange, M. [1 ]
Massicotte, J. [1 ]
Sicard, E. [1 ]
Lefebvre, M. [1 ]
机构：
[1] Algorithme Pharma Inc, Laval, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects
    Dingemanse J.
    Hoever P.
    Drugs in R&D, 2013, 13 (2) : 145 - 151
  • [2] Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects
    Abdul, Mohi Iqbal Mohammed
    Jiang, Xuemin
    Williams, Kenneth M.
    Day, Richard O.
    Roufogalis, Basil D.
    Liauw, Winston S.
    Xu, Hongmei
    Matthias, Anita
    Lehmann, Reginald P.
    McLachlan, Andrew J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 508 - 515
  • [3] Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects
    Bruderer, Shirin
    Okubo, Kaori
    Mukai, Hideya
    Mant, Tim
    Dingemanse, Jasper
    CLINICAL THERAPEUTICS, 2016, 38 (05) : 1228 - 1236
  • [4] Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan and Warfarin in Healthy Subjects
    Shoaf, Susan E.
    Mallikaarjun, Suresh
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02): : 67 - 75
  • [5] Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects
    McCracken, N.
    Lahu, G.
    Bethke, T. D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (06) : 388 - 396
  • [6] A PHARMACOKINETIC INTERACTION STUDY BETWEEN HSR-803 100 mg TABLETS AND RANITIDINE HYDROCHLORIDE 300 mg TABLETS IN HEALTHY MALE AND FEMALE VOLUNTEERS
    Rufiange, M.
    Massicotte, J.
    Morin, J.
    Sicard, E.
    Lefebvre, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S105 - S105
  • [7] Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
    Yoo, Hyounggyoon
    Kim, Yun
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, SeungHwan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5179 - 5187
  • [8] Pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and warfarin in healthy subjects
    Battle, MM
    Klamerus, KJ
    Neefe, DL
    Georgieff, IS
    Mayer, PR
    JOURNAL OF HYPERTENSION, 1998, 16 : S123 - S123
  • [9] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [10] Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects
    He, Xuejun
    Liu, Gege
    Chen, Xinyan
    Wang, Yaqin
    Liu, Ran
    Wang, Changmao
    Huang, Yunzhe
    Shen, Jie
    Jia, Yuanwei
    CLINICAL THERAPEUTICS, 2023, 45 (07) : 655 - 661
12345